Meeting Archive:
New Quality Indicator Set for Systemic Sclerosis

This webinar has been recorded and will be available soon at

Meeting Description:

A group of expert rheumatologists from around the world have released a new set of quality indicators for systemic sclerosis.  These guidelines will help to ensure the best measure of disease progression as well as control of associated conditions like pulmonary hypertension. Quality indicators are an important part of treating any disease and help advance patient care by developing a better understanding of the healthcare process.  Join Daniel Furst, MD as he discusses how these new indicators will help improve care during diagnosis, follow up appointments and treatment.

View the abstract
Date: Thu, Sep 29, 2011
Time: 02:00 PM EDT
Duration: 1 hour
Host(s): PHA Online University
 Presenter Information
Daniel E. Furst, MD
Speaker Photo

University of California
Los Angeles, CA

Daniel E. Furst is the first Carl M. Pearson Professor of Medicine at the University of California, Los Angeles (UCLA), Medical Center.  Dr. Furst received his MD from Johns Hopkins University and two fellowships (Rheumatology in clinical pharmacology).

Dr. Furst has been on a number of national committees concerned with rheumatic therapeutics. He recently was co-leader of the ACR recommendations for the use of non-biologic and biologic therapies in RA and is a Master of the ACR. Dr. Furst has published more than  450 articles and 14 books, including more than 220 research articles. Dr. Furst’s areas of research interest include the clinical pharmacology of anti-rheumatic drugs and biologics, and the pathophysiology and treatment of systemic sclerosis.